Page last updated: 2024-08-17

levodopa and jaw

levodopa has been researched along with jaw in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (12.50)	18.7374
1990's	1 (12.50)	18.2507
2000's	2 (25.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jeste, DV; Karson, CN; LeWitt, PA; Wyatt, RJ	1
Hammerstad, JP; Robertson, LT	1
Betz, AJ; Bibbiani, F; Chase, TN; Davis, RE; Kielaite, A; Salamone, JD; Vanover, KE; Weber, SM; Weiner, DM	1
Ballero, M; Kasture, S; Longoni, R; Morelli, M; Pinna, A; Pontis, S; Schintu, N; Simola, N; Spina, L	1
Cristalli, G; Morelli, M; Pinna, A; Pontis, S; Schintu, N; Simola, N; Tronci, E; Volpini, R	1
Burchiel, KJ; Carlson-Kuhta, P; Hogarth, P; Horak, FB; Robertson, LT; St George, RJ	1
LeDoux, MS; Pfeiffer, RF	1
Amernik, K; Gołąb-Janowska, M; Honczarenko, K; Nowacki, P; Pawlukowska, W; Rotter, I; Safranow, K	1

Trials

2 trial(s) available for levodopa and jaw

Article	Year
Jaw movement dysfunction related to Parkinson's disease and partially modified by levodopa. Journal of neurology, neurosurgery, and psychiatry, 1996, Volume: 60, Issue:1 Topics: Antiparkinson Agents; Electromagnetic Fields; Electromyography; Female; Humans; Jaw; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease	1996
Site of deep brain stimulation and jaw velocity in Parkinson disease. Journal of neurosurgery, 2011, Volume: 115, Issue:5 Topics: Aged; Antiparkinson Agents; Biomechanical Phenomena; Combined Modality Therapy; Deep Brain Stimulation; Deglutition Disorders; Double-Blind Method; Female; Globus Pallidus; Humans; Jaw; Levodopa; Male; Middle Aged; Parkinson Disease; Speech Disorders; Subthalamic Nucleus; Treatment Outcome	2011

Article

Year

Jaw movement dysfunction related to Parkinson's disease and partially modified by levodopa.

Journal of neurology, neurosurgery, and psychiatry, 1996, Volume: 60, Issue:1

Topics: Antiparkinson Agents; Electromagnetic Fields; Electromyography; Female; Humans; Jaw; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease

1996

Site of deep brain stimulation and jaw velocity in Parkinson disease.

Journal of neurosurgery, 2011, Volume: 115, Issue:5

Topics: Aged; Antiparkinson Agents; Biomechanical Phenomena; Combined Modality Therapy; Deep Brain Stimulation; Deglutition Disorders; Double-Blind Method; Female; Globus Pallidus; Humans; Jaw; Levodopa; Male; Middle Aged; Parkinson Disease; Speech Disorders; Subthalamic Nucleus; Treatment Outcome

2011

Other Studies

6 other study(ies) available for levodopa and jaw

Article	Year
A comparison of two iatrogenic dyskinesias. The American journal of psychiatry, 1983, Volume: 140, Issue:11 Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Extremities; Facial Muscles; Female; Humans; Iatrogenic Disease; Jaw; Levodopa; Male; Middle Aged; Parkinson Disease; Tongue	1983
A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model. Pharmacology, biochemistry, and behavior, 2008, Volume: 90, Issue:4 Topics: Animals; Data Interpretation, Statistical; Dopamine Agents; Dyskinesia, Drug-Induced; Jaw; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Piperidines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Tremor; Urea	2008
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease. Neurotoxicity research, 2009, Volume: 15, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Antiparkinson Agents; CD11b Antigen; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Jaw; Levodopa; Locomotion; Male; Mice; Mice, Inbred C57BL; Movement; Mucuna; Neuroprotective Agents; Oxidopamine; Parasympathomimetics; Parkinson Disease; Phytotherapy; Rats; Rats, Sprague-Dawley; Seeds; Sympatholytics; Tacrine; Time Factors; Vibrissae	2009
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug. Neuropharmacology, 2010, Volume: 58, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenine; Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Brain Chemistry; CD11b Antigen; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Gene Expression Regulation; Jaw; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Movement; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Psychomotor Performance; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rotarod Performance Test; Time Factors; Triazoles; Vibrissae	2010
Levodopa-induced lateral jaw deviation dystonia. Parkinsonism & related disorders, 2015, Volume: 21, Issue:7 Topics: Aged; Dystonia; Female; Humans; Jaw; Levodopa	2015
Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease. Neurologia i neurochirurgia polska, 2015, Volume: 49, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Articulation Disorders; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Jaw; Levodopa; Lip; Male; Middle Aged; Parkinson Disease; Phonation; Phonetics; Range of Motion, Articular; Reflex, Abnormal; Respiration; Severity of Illness Index	2015